SNCA and Parkinson disease: Finally, we examined α‐synuclein overexpression, a specific biomarker for parkinsonism with PINK1 defects and leading to dopaminergic loss, by quantifying mRNA abundance for its gene SNCA, as documented in several previous studies.22, 23